Office of The Director, Office of Science Policy, Office of Biotechnology Activities; Amended Notice of Meeting, 71747 [2016-25072]

Download as PDF Federal Register / Vol. 81, No. 201 / Tuesday, October 18, 2016 / Notices limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.375, Minority Biomedical Research Support; 93.821, Cell Biology and Biophysics Research; 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.862, Genetics and Developmental Biology Research; 93.88, Minority Access to Research Careers; 93.96, Special Minority Initiatives; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS) the Department of Health and Human Services: Last name Avula ......................... Corierre ..................... Del Vecchio ............... Enomoto .................... Etzinger ..................... Feit ............................ Goldstein ................... Harding ...................... Hendriksson .............. Johnson ..................... Kade .......................... Lopez ........................ Power ........................ Wheeles .................... First name Deepa Michael Paolo Kana Michael Monica Gregory Frances Marla Kimberly Daryl Elizabeth Kathryn Timothy (NIH) Dated: October 12, 2016. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2016–25071 Filed 10–17–16; 8:45 am] BILLING CODE 4140–01–P Michael Etzinger, Executive Officer and Director, Office of Management, Technology and Operations. Carlos Castillo, SAMHSA Committee Management Officer, Office of Policy, Planning and Innovation. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of The Director, Office of Science Policy, Office of Biotechnology Activities; Amended Notice of Meeting [FR Doc. 2016–25099 Filed 10–17–16; 8:45 am] BILLING CODE 4151–17–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of General Medical Sciences; Notice of Closed Meeting Lhorne on DSK30JT082PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of General Medical Sciences Special Emphasis Panel; Review of Mira Applications. Date: November 9–10, 2016. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Washington Plaza Hotel, Ten Thomas Circle, Washington, DC 20005. Contact Person: Lisa A. Dunbar, Scientific Review Officer, Office of Scientific Review, National Institute of General Medical Sciences, National Institutes of Health, 45 Center Drive, Room 3AN12, Bethesda, MD 20892, 301–594–2849, dunbarl@mail.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing VerDate Sep<11>2014 13:19 Oct 17, 2016 Jkt 241001 Notice is hereby given of a change in the meeting of the National Science Advisory Board for Biosecurity, November 04, 2016, 12:00 p.m. to November 04, 2016, 03:00 p.m., National Institutes of Health, 6705 Rockledge Drive, Suite 750, Bethesda, MD 20892 which was published in the Federal Register on October 11, 2016, 81FR 196. The call-in number has changed to 1 (866) 939–3921. The meeting date, time and location remains the same. The meeting is open to the public. Dated: October 12, 2016. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2016–25072 Filed 10–17–16; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Drug Abuse; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose PO 00000 Frm 00059 Fmt 4703 Sfmt 4703 71747 confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; Growing Great Ideas: Research Education Course in Product Development and Entrepreneurship for Life Science Researchers (R25). Date: October 24, 2016. Time: 1:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Gerald L. McLaughlin, Ph.D., Scientific Review Officer, Office of Extramural Policy and Review, National Institute on Drug Abuse, NIH, DHHS, 6001 Executive Blvd., Room 4238, MSC 9550, Bethesda, MD 20892–9550, 301–827–5819, gm145a@nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; Exploratory Studies of Smoking Cessation Interventions for People with Schizophrenia. Date: November 2, 2016. Time: 9:00 a.m. to 12:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Nadine Rogers, Ph.D., Scientific Review Officer, Office of Extramural Policy and Review, National Institute on Drug Abuse, NIH, DHHS, 6001 Executive Blvd., Room 4229, MSC 9550, Bethesda, MD 20892–9550, 301–827–5840, rogersn2@nida.nih.gov. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; NIDA Medications Development. Date: November 4, 2016. Time: 8:30 a.m. to 5:00 p.m. Agenda: To review and evaluate cooperative agreement applications. Place: Hilton Garden Inn Bethesda, 7301 Waverly Street, Bethesda, MD 20814. Contact Person: Jose F. Ruiz, Ph.D., Scientific Review Officer, Office of Extramural Policy and Review, National Institute on Drug Abuse, NIH, Room 4228, MSC 9550, 6001 Executive Blvd., Bethesda, MD 20892–9550, 301–827–5842, ruizjf@ nida.nih.gov. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; Multisite Clinical Trials. Date: November 9, 2016. Time: 3:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. E:\FR\FM\18OCN1.SGM 18OCN1

Agencies

[Federal Register Volume 81, Number 201 (Tuesday, October 18, 2016)]
[Notices]
[Page 71747]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-25072]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of The Director, Office of Science Policy, Office of 
Biotechnology Activities; Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the National 
Science Advisory Board for Biosecurity, November 04, 2016, 12:00 p.m. 
to November 04, 2016, 03:00 p.m., National Institutes of Health, 6705 
Rockledge Drive, Suite 750, Bethesda, MD 20892 which was published in 
the Federal Register on October 11, 2016, 81FR 196.
    The call-in number has changed to 1 (866) 939-3921. The meeting 
date, time and location remains the same. The meeting is open to the 
public.

    Dated: October 12, 2016.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-25072 Filed 10-17-16; 8:45 am]
 BILLING CODE 4140-01-P